Nanomaterial for Better Insulin Effects; New Approach to Effectively Treat Type 1 & 2 Diabetes
In a new study, researchers compared the treatment effects of a chemical compound to the effects of insulin alone and the nanomaterial alone in mouse models of type 1 diabetes. According to a Medical Xpress report, the measures of blood sugar results and insulin-related activity in the mice's brains treated with the combination treatment came close to those of healthy animals, and these same mice did better on tests of their memory and thinking. This same report also specified that there might be a way, later on, to enhance diabetes treatment, with better blood sugar control, its use by the brain, and a lower neurological disorder risk, by attaching insulin to a specifically designed nanomaterial. Specifically, researchers at the Ohio State University have developed a compound that consists of insulin bound to a string of amino acids, including a group of antioxidants. Earlier research of mice published in Biomaterials suggested these anti-diabetes properties of nanomaterial includ